| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol 2HCL |
(5S,6S,9R)-5-氨基-6-(2,3-二氟苯基)-6,7,8,9-四氫-5H-環(huán)庚[B]吡啶-9-醇二鹽酸鹽 |
1373116-07-4 |
詳細(xì)
|
| (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-ol |
(5S,6S,9R)-6-(2,3-二氟苯基)-6,7,8,9-四氫-9-氧基-5H-環(huán)庚并[B]吡啶-5-氨基 |
1373116-05-2 |
詳細(xì)
|
| 1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one |
1-(1-(1H-咪唑酸乙酯-1-羰基)吡啶-4-YL)-1H-咪唑[4,5-B]吡啶-2(3H)-酮 |
1373116-06-3 |
詳細(xì)
|
| Pirtobrutinib |
吡托布魯替尼 |
1297538-32-9 |
詳細(xì)
|
| (1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hydrochloride |
(S)-(1,1,1-三氟丙-2-基)肼鹽酸鹽 |
2764851-03-6 |
詳細(xì)
|
| Benzoic acid, 4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]- |
4-[[(5-氟-2-甲氧基苯甲?；?氨基]甲基]苯甲酸 |
1571888-11-3 |
詳細(xì)
|
| Orforglipron |
奧格列龍 |
2212020-52-3 |
詳細(xì)
|
| (S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one hydrochloride |
(S) -1-(4-氟-1-甲基-1H-吲唑-5-基)-3-(2-(4-氟-3,5-二甲基苯基)-4-甲基-4,5,6,7-四氫-2H-吡唑并[4,3-C]吡啶-3-基)-1H-咪唑-2(3H)-酮鹽酸鹽 |
2212022-57-4 |
詳細(xì)
|
| 5-Bromo-4-fluoro-1-methyl-1H-indazole |
5-溴-4-氟-1-甲基-1H-吲唑 |
1784678-61-0 |
詳細(xì)
|
| 1H-Indole-2-carboxylic acid, 5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]- |
(S)-5-(2,2-二甲基四氫-2H-吡喃-4-基)-1H-吲哚-2-甲酸 |
2212021-78-6 |
詳細(xì)
|
| 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-5-[(4S)-2,2-dimethyloxan-4-yl]-N-methyl-N-phenylindole-2-carboxamide |
1-((1S,2S)-1-氰基-2-甲基環(huán)丙基)-5-((4S)-2,2-二甲基四氫吡喃-4-基)-N-甲基-N-苯基吲哚-2-甲酰胺 |
2212021-81-1 |
詳細(xì)
|
| 1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
1-芐基-4-羥基-2-甲基-1H-苯并咪唑-6-羧酸 |
1640981-19-6 |
詳細(xì)
|
| (R)-5,7-difluorochroman-4-ol |
R-5,7-二氟苯并二氫吡喃-4-醇 |
1270294-05-7 |
詳細(xì)
|
| Edoxaban Intermediate A7 |
EDB-A7 |
929693-31-2 |
詳細(xì)
|
| Retatrutide |
瑞他魯肽 |
2381089-83-2 |
詳細(xì)
|
| 1-Piperidinepropanol |
1-哌啶丙醇 |
104-58-5 |
詳細(xì)
|